The stock fell nearly 7% Wednesday and remains attractive here.
Big pharma firm looks good overall, but is falling with the rest of Wall Street.
It backs up our view that the U.S. growth story remains intact and that we should invest in domestically focused retailers.
Here are updates on two stocks in the portfolio that are in focus.
Sign up to get started or log in to see your watchlist.
Enter a symbol above to add it to your watchlist.
A confirmation email has been sent to the address provided during registration. Please click on the appropriate link to confirm your email address.